These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. P & T Committee interview: communication and education contribute to an effective formulary system. Hinthorn D; Godwin H Hosp Formul; 1989 May; 24(5):281-4, 286-7. PubMed ID: 10292977 [TBL] [Abstract][Full Text] [Related]
23. P & T Committee interview: Establishing and maintaining a dynamic formulary. Rostand S; Lazarus H Hosp Formul; 1988 Jan; 23(1):48-53. PubMed ID: 10285373 [TBL] [Abstract][Full Text] [Related]
25. A survey of Pharmacy and Therapeutic committees across Canada: scope and responsibilities. Mittmann N; Knowles S Can J Clin Pharmacol; 2009; 16(1):e171-7. PubMed ID: 19242000 [TBL] [Abstract][Full Text] [Related]
26. P&T committee: an approach to formulary consideration of antimicrobial agents--introduction. Andriole VT; Ryan JL Hosp Formul; 1981 Jun; 16(6):619, 623. PubMed ID: 10251442 [No Abstract] [Full Text] [Related]
27. Preparing the P & T committee agenda for new drug requests. Standish RC; Evans PJ; Bell JE Hosp Formul; 1984 Sep; 19(9):792, 795-800. PubMed ID: 10267929 [TBL] [Abstract][Full Text] [Related]
28. Formulary management at a tertiary-care facility: P&T committee interview. Lucas RV; Abramowitz PW Hosp Formul; 1988 Feb; 23(2):162-8, 172-3. PubMed ID: 10286021 [TBL] [Abstract][Full Text] [Related]
29. What process does your P&T Committee use to obtain staff physicians' input regarding formulary decisions? Tompkins GC Hosp Formul; 1992 Feb; 27(2):197. PubMed ID: 10116717 [No Abstract] [Full Text] [Related]
30. The evolution of an effective P & T Committee: advice from the chairman. Williams RR Hosp Formul; 1986 Dec; 21(12):1232-5, 1243. PubMed ID: 10279772 [TBL] [Abstract][Full Text] [Related]
31. What should your formulary look like? Lanser EG Healthc Exec; 2002; 17(1):52. PubMed ID: 11822245 [No Abstract] [Full Text] [Related]
32. Hospitals defend formulary decisions against industry attacks. Talley CR Am J Hosp Pharm; 1978 Sep; 35(9):1154-5. PubMed ID: 696756 [No Abstract] [Full Text] [Related]
33. Guidelines on the operation of the pharmacy and therapeutics committee and formulary. Linkewich JA; Prevoznik SJ Hosp Pharm; 1979 Jan; 14(1):7-10, 13, 16-9 passim. PubMed ID: 10240149 [No Abstract] [Full Text] [Related]
34. The other side of the fence: hospital P&T committee members' role in drug selection. Archambault GF Med Mark Media; 1978 May; 13(5):48, 50, 52 passim. PubMed ID: 10307029 [No Abstract] [Full Text] [Related]
35. P & T Committee interview: strategies to ensure an effective formulary system. Riff L; Hutchinson R Hosp Formul; 1988 Nov; 23(11):901-4, 907-8. PubMed ID: 10290754 [TBL] [Abstract][Full Text] [Related]
36. Prospective reimbursement and DRGs: implications for formulary management. Enright SM Hosp Formul; 1983 Oct; 18(10):989-90, 999-1000. PubMed ID: 10310246 [No Abstract] [Full Text] [Related]
38. P & T Committee problem-solving in a Canadian specialty hospital. Feld R Hosp Formul; 1986 Jul; 21(7):778-9, 783-4. PubMed ID: 10277344 [TBL] [Abstract][Full Text] [Related]
39. Formulary status of intravenous immunoglobulins in selected hospitals. Hatton RC; Doering PL; Fakhoury M; Williams RB Am J Hosp Pharm; 1988 Nov; 45(11):2377-9. PubMed ID: 3228096 [No Abstract] [Full Text] [Related]